iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26749427
PubMed Central
PMC4755222
DOI
10.1002/anie.201508642
Knihovny.cz E-zdroje
- Klíčová slova
- HPMA, antibody mimetics, molecular recognition, polymer conjugates, protein targeting,
- MeSH
- hydrofobní a hydrofilní interakce MeSH
- lidé MeSH
- molekulární mimikry * MeSH
- nádorové buněčné linie MeSH
- polymery chemie MeSH
- protilátky chemie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- polymery MeSH
- protilátky MeSH
Antibodies are indispensable tools for biomedicine and anticancer therapy. Nevertheless, their use is compromised by high production costs, limited stability, and difficulty of chemical modification. The design and preparation of synthetic polymer conjugates capable of replacing antibodies in biomedical applications such as ELISA, flow cytometry, immunocytochemistry, and immunoprecipitation is reported. The conjugates, named "iBodies", consist of an HPMA copolymer decorated with low-molecular-weight compounds that function as targeting ligands, affinity anchors, and imaging probes. We prepared specific conjugates targeting several proteins with known ligands and used these iBodies for enzyme inhibition, protein isolation, immobilization, quantification, and live-cell imaging. Our data indicate that this highly modular and versatile polymer system can be used to produce inexpensive and stable antibody substitutes directed toward virtually any protein of interest with a known ligand.
Zobrazit více v PubMed
Nord K., Gunneriusson E., Ringdahl J., Stahl S., Uhlen M., Nygren P. A., Nat. Biotechnol. 1997, 15, 772. PubMed
Binz H. K., Stumpp M. T., Forrer P., Amstutz P., Pluckthun A., J. Mol. Biol. 2003, 332, 489. PubMed
Ellington A. D., Szostak J. W., Nature 1990, 346, 818. PubMed
McEnaney P. J., Fitzgerald K. J., Zhang A. X., E. F. Douglass, Jr. , Shan W., Balog A., Kolesnikova M. D., Spiegel D. A., J. Am. Chem. Soc. 2014, 136, 18034. PubMed PMC
Hoshino Y., Koide H., Urakami T., Kanazawa H., Kodama T., Oku N., Shea K. J., J. Am. Chem. Soc. 2010, 132, 6644; PubMed PMC
Wulff G., Angew. Chem. Int. Ed. Engl. 1995, 34, 1812;
Angew. Chem. 1995, 107, 1958.
Haag R., Kratz F., Angew. Chem. Int. Ed. 2006, 45, 1198; PubMed
Angew. Chem. 2006, 118, 1218;
Kopeček J., Kopečková P., Adv. Drug Delivery Rev. 2010, 62, 122. PubMed PMC
Šubr V., Kostka L., Strohalm J., Etrych T., Ulbrich K., Macromolecules 2013, 46, 2100.
Lapidus R. G., Tiffany C. W., Isaacs J. T., Slusher B. S., Prostate 2000, 45, 350; PubMed
Robinson M. B., Blakely R. D., Couto R., Coyle J. T., J. Biol. Chem. 1987, 262, 14498. PubMed
Tykvart J., Schimer J., Barinkova J., Pachl P., Postova-Slavetinska L., Majer P., Konvalinka J., Sacha P., Bioorg. Med. Chem. 2014, 22, 4099. PubMed
Knedlík T., Navratil V., Vik V., Pacik D., Sacha P., Konvalinka J., Prostate 2014, 74, 768. PubMed
Liu H., Rajasekaran A. K., Moy P., Xia Y., Kim S., Navarro V., Rahmati R., Bander N. H., Cancer Res. 1998, 58, 4055. PubMed
Liu H., Moy P., Kim S., Xia Y., Rajasekaran A., Navarro V., Knudsen B., Bander N. H., Cancer Res. 1997, 57, 3629. PubMed
Krausslich H. G., Ingraham R. H., Skoog M. T., Wimmer E., Pallai P. V., Carter C. A., Proc. Natl. Acad. Sci. USA 1989, 86, 807. PubMed PMC
Eder J., Hommel U., Cumin F., Martoglio B., Gerhartz B., Curr. Pharm. Des. 2007, 13, 271. PubMed
Huang Z., Hwang P., Watson D. S., Cao L., F. C. Szoka, Jr. , Bioconjugate Chem. 2009, 20, 1667. PubMed PMC
Ma Y., Pan G. Q., Zhang Y., Guo X. Z., Zhang H. Q., Angew. Chem. Int. Ed. 2013, 52, 1511; PubMed
Angew. Chem. 2013, 125, 1551;
Shinde S., El-Schich Z., Malakpour A., Wan W., Dizeyi N., Mohammadi R., Rurack K., Gjorloff Wingren A., Sellergren B., J. Am. Chem. Soc. 2015, 137, 13908. PubMed
The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery
Polymer-Tethered Quenched Fluorescent Probes for Enhanced Imaging of Tumor-Associated Proteases
Polymer-tethered quenched fluorescent probes for enhanced imaging of tumor associated proteases
Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers
A radioligand binding assay for the insulin-like growth factor 2 receptor
Random protein sequences can form defined secondary structures and are well-tolerated in vivo